Vitaspring Biomedical Co. Ltd. SEC filings VSBC

Vitaspring Biomedical Co. Ltd. has 74 filings in SEC EDGAR's recent list, going back to Mar 6, 2017. Its latest annual report, Form 10-K, was filed on Jun 17, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 17, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on January 31.

Vitaspring Biomedical Co. Ltd. SEC filings
Form Description Filed Period
NT 10-Q Form nt 10-q Sep 15, 2026 Jul 31, 2026
NT 10-K Filing May 1, 2023 Jan 31, 2023
NT 10-Q Filing Dec 13, 2022 Oct 31, 2022
NT 10-Q Filing Dec 15, 2021 Oct 31, 2021
NT 10-Q Filing Sep 14, 2020 Jul 31, 2020
NT 10-Q Filing Jun 15, 2020 Apr 30, 2020
NT 10-K Filing May 1, 2020 Jan 31, 2020
NT 10-K Form nt 10-k Apr 30, 2018 Jan 31, 2018
EFFECT Filing Jun 7, 2017 —
CORRESP Letter to the SEC Jun 5, 2017 —
UPLOAD Letter from the SEC Apr 25, 2017 —
UPLOAD Letter from the SEC Apr 18, 2017 —
UPLOAD Letter from the SEC Apr 5, 2017 —
UPLOAD Letter from the SEC Mar 28, 2017 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
VSBC (OTC)
Fiscal year ends
January 31
Incorporated in
NV
Headquarters
Riverside, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1697884
Former names
Shemn Corp. (until Apr 27, 2020)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.